Shixi Liu

West China University of Medical Sciences, Chengdu, Sichuan Sheng, China

Are you Shixi Liu?

Claim your profile

Publications (43)70.96 Total impact

  • Article: MicroRNA: A new approach to treat different endotypes of nasal polyps.
    Peng Zhou, Shixi Liu, Claus Bachert
    Medical Hypotheses 12/2012; · 1.39 Impact Factor
  • Article: [Clinical effectiveness and safety of sanchi tong shu capsule in the treatment of aural vertigo: a multi-center randomized controlled clinical trial].
    [show abstract] [hide abstract]
    ABSTRACT: To evaluate the clinical effectiveness and safety of Sanchi Tong Shu capsule in the treatment of common aural vertigo. A multi-center randomized controlled trial was designed to study 206 vertigo patients who were randomly allocated into one of the two groups. One group was treated with Sanchi Tong Shu capsule for 14 days, another group was treated with betahistine mesilate tablets for 14 days. The clinical effectiveness rates of the two groups were 84.86% and 90.92% respectively according to FAS analysis and 84.76%, 90.92% respectively according to PPS analysis. No statistic significance difference was found between the two groups (P > 0.05). After 14 days treatment, total DHI and all the subsection (including body, emotion and fuction) scores of the two groups were all decreased compared with treatment before (P < 0.01). Compared the difference value of the total DHI and subsection scores before and after treatment, the two groups have no difference (P > 0.05). The adverse effective rate of the two groups were 3.29% and 7.84% respectively and there was no statistic difference between the two groups (P > 0.05). Sanchi Tong Shu capsule is a safe and effective drug for the treatment of common aural vertigo.
    Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology 04/2012; 26(7):295-9.
  • Article: [Significance expression and relationships with endothelin-1, matrix metalloproteinase-9 in the laryngeal carcinoma].
    [show abstract] [hide abstract]
    ABSTRACT: To evaluate the expression of endothelin-1(ET-1) and matrix metalloproteinase-9 (MMP-9) in laryngeal carcinoma and their correlations with clinical features. The expression of ET-1 and MMP-9 was detected by immunohistochemical method in 58 specimens of laryngeal carcinoma, 28 specimens of polyps of vocal cord and 19 specimens of normal laryngeal tissues. The expressions of ET-1, MMP-9 in laryngeal carcinoma were remarkably higher,compared to polyps of vocal cord and normal laryngeal tissues (P < 0.05). The expression of ET-1, MMP-9 was associated with clinical stage, T stage and lymph node metastasis. Expression levels of ET-land MMP-9 correlated significantly with each other (r(s) = 0.693, P < 0.05). The expression of ET-1 and MMP-9 may be the vital indexes in laryngeal carcinoma.
    Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology 03/2012; 26(6):245-7, 251.
  • Source
    Article: Reliability and validity of the chinese (mandarin) tinnitus handicap inventory.
    [show abstract] [hide abstract]
    ABSTRACT: The Tinnitus Handicap Inventory (THI) is a commonly used self-reporting tinnitus questionnaire. We undertook this study to determine the reliability and validity of the Chinese-Mandarin version of the Tinnitus Handicap Inventory (THI-CM) for measuring tinnitus-related handicaps. We tested the test-retest reliability, internal reliability, and construct validity of the THI-CM. Two-hundred patients seeking treatment for primary or secondary tinnitus in Southwest China were asked to complete THI-CM prior to clinical evaluation. Patients were evaluated by a clinician using standard methods, and 40 patients were asked to complete THI-CM a second time 14±3 days after the initial interview. The test-retest reliability of THI-CM was high (Pearson correlation, 0.98), as was the internal reliability (Cronbach's α, 0.93). Factor analysis indicated that THI-CM has a unifactorial structure. The THI-CM version is reliable. The total score in THI-CM can be used to measure tinnitus-related handicaps in Mandarin-speaking populations.
    Clinical and Experimental Otorhinolaryngology 03/2012; 5(1):10-6. · 0.92 Impact Factor
  • Article: Reply.
    The Journal of allergy and clinical immunology 03/2011; · 9.17 Impact Factor
  • Article: Repetitive transcranial magnetic stimulation for tinnitus.
    [show abstract] [hide abstract]
    ABSTRACT: Tinnitus is the perception of sound, in the ear or in the head, in the absence of any external acoustic stimulation. Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive means of inducing electrical currents in the brain, and has received increasing attention in recent years for the treatment of many neuropsychiatric disorders, including tinnitus. To assess the effectiveness and safety of rTMS versus placebo in patients with tinnitus. We searched the Cochrane Ear, Nose and Throat Disorders Group Trials Register; the Cochrane Central Register of Controlled Trials (CENTRAL); PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; ICTRP and additional sources for published and unpublished trials. The date of the most recent search was 24 May 2011. Randomised controlled trials of rTMS versus sham rTMS. Two review authors reviewed the titles, abstracts and keywords of all records retrieved. Three review authors independently collected and extracted data, and assessed the risk of bias of the trials. Five trials comprising of 233 participants met our inclusion criteria. Each study described the use of a different rTMS device that delivered different waveforms at different frequencies. All five trials were relatively small studies but generally they demonstrated a low risk of bias.When considering the impact of tinnitus on patients' quality of life, the results of only one study demonstrated a statistically significant improvement in Tinnitus Handicap Inventory (THI) scores at four months follow-up (defined as a 'partial improvement' by the study authors (THI reduction of 21% to 80%)) when low-frequency rTMS was compared with a sham control treatment. However, no statistically significant improvement was demonstrated by another two studies that considered rTMS at the same frequency. Furthermore, this single positive finding should be taken in the context of the many different variables which were recorded at many different points in time by the study authors.In accordance with our pre-specified subgroup analysis we extracted the data from one study to consider the differential effectiveness between 'lower' low-frequency rTMS (1 Hz) and 'higher' low-frequency rTMS (10 Hz, 25 Hz). In doing this we were able to demonstrate a statistically significant difference between rTMS employing a frequency of 1 Hz and the sham group when considering tinnitus severity and disability after four months follow-up ('partial' improvement). However, no statistically significant difference was demonstrated between 10 Hz and 25 Hz rTMS, and the sham control group, when considering the severity and disability of tinnitus at four months follow-up.When considering tinnitus loudness in patients undergoing rTMS we were able to demonstrate a statistically significant reduction in tinnitus loudness when the results of two studies were pooled (risk ratio 4.17, 95% confidence interval 1.30 to 13.40). However, this finding was based on two small trials and consequently the confidence interval was particularly wide.No serious adverse effects were reported in any of the trials. There is very limited support for the use of low-frequency rTMS for the treatment of patients with tinnitus. When considering the impact of tinnitus on patients' quality of life, support is from a single study with a low risk of bias based on a single outcome measure at a single point in time. When considering the impact on tinnitus loudness, this is based on the analysis of pooled data with a large confidence interval.Studies suggest that rTMS is a safe treatment for tinnitus in the short-term, however there were insufficient data to provide any support for the safety of this treatment in the long-term.More prospective, randomised, placebo-controlled, double-blind studies with large sample sizes are needed to confirm the effectiveness of rTMS for tinnitus patients. Uniform, validated, tinnitus-specific questionnaires and measurement scales should be used in future studies.
    Cochrane database of systematic reviews (Online) 01/2011; · 5.72 Impact Factor
  • Source
    Article: Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice.
    [show abstract] [hide abstract]
    ABSTRACT: To conserve laryngeal function and elevate living quality of laryngeal squamous cell carcinoma (LSCC) patients, we designed antisense oligodeoxynucleotides (AS-ODNs) to reduce expression of ATM and to enhance the apoptosis of hep-2 (Human epidermoid laryngeal carcinoma) cells to radiation in vitro and in vivo. The expression of ATM mRNA and protein in hep-2 cells were examined by real-time quantitative PCR and western blotting respectively. Clonogenic survival assay was carried out to detect the survival ability of hep-2 cells after irradiation, and analyzed the cell apoptosis by flow cytometry. The volume of solid tumors was measured, while TUNEL assay and western blotting used to analyze cell apoptosis and protein expression after irradiation. The relative ATM mRNA and protein expression in hep-2 cells treated with ATM AS-ODNs were decreased to 11.03 ± 2.51% and 48.14 ± 5.53% of that in untreated cells respectively (P <0.05). After irradiation, the survival fraction (SF) of cells treated with ATM AS-ODNs was lower than that of other groups at the same dose of radiation (P < 0.05). The inhibition rate in hep-2 cells solid tumor exposed to X-ray alone was 5.95 ± 4.52%, while it was 34.28 ± 2.43% in the group which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The apoptotic index for the group irradiated in combination with ATM AS-ODNs injection was 17.12 ± 4.2%, which was significantly higher than that of others (P < 0.05). AS-ODNs of ATM reduce ATM expression and enhance hep-2 cells apoptosis to radiation in vitro and in vivo.
    Journal of Experimental & Clinical Cancer Research 01/2011; 30:43. · 2.15 Impact Factor
  • Article: Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma.
    [show abstract] [hide abstract]
    ABSTRACT: Nasal polyps often are associated with asthma. The phenotype of these patients is unknown. To identify the mucosal factors associated with asthma comorbidity, we analyzed the inflammatory patterns of nasal polyps. Nasal polyps from 70 Belgian patients, 34% with asthma, were analyzed for type of inflammation, T-cell cytokines, and IgE antibodies to Staphylococcus aureus enterotoxins. The same investigations were repeated in 93 Chinese patients with polyps, a group with a low asthma comorbidity rate (8%). In Belgian patients with polyps, 54% of samples showed eosinophilic inflammation. A classification tree evaluation identified IL-5 as the main positive determinant. Enterotoxin IgE in tissue (37%) was associated with significantly increased total IgE and eosinophil cationic protein concentrations. Expression of enterotoxin IgE, total IgE at greater than 1,442 kU/L, and eosinophil cationic protein at greater than 17,109 μg/L in samples with a total IgE concentration of greater than 246 kU/L significantly predicted asthma (odds ratio, 5.8-13). Only 7.5% of the samples from Chinese patients with polyps showed eosinophilic inflammation. IL-5 was confirmed as a positive determinant of eosinophilic inflammation, and enterotoxin IgE in tissue (17% of patients) was associated with significantly increased total IgE and eosinophil cationic protein concentrations. The expression of IL-5 or total IgE at greater than 790 kU/L in samples with an IL-5 concentration of greater than 194 pg/mL significantly predicted comorbid asthma (odds ratio, 17.2-96). Mucosal inflammation in nasal polyps orchestrated by T(H)2 cytokines and amplified by S aureus enterotoxins is characterized by an increased eosinophilic inflammation and formation of IgE antibodies. This phenotype is associated with comorbid asthma in white and Asian patients with nasal polyps.
    The Journal of allergy and clinical immunology 11/2010; 126(5):962-8, 968.e1-6. · 9.17 Impact Factor
  • Article: [The cytoskeleton and immigration of laryngeal squamous carcinoma cell affected by Fascin-1 expression].
    [show abstract] [hide abstract]
    ABSTRACT: This study sought to detect the effect of Fascin-1 expression on the cytoskeleton and immigration of laryngeal squamous carcinoma cell. In the experiment, Fascin-1 expression in Hep-2 cells was inhibited by small interfering RNA. The cytoskeleton of Hep-2 cells was observed with the use of laser scanning confocal fluorescence microscope. Millicell insert was applied to detect the immigration of Hep-2 cells in vitro. The results showed that the integrity of cytoskeleton in Hep-2 cells was broken with the down-regulation of Fascin-1 expression and the immigration ability was decreased significantly (P < 0.05). The inhibiting ratio of cell immigration was 44.6 +/- 6.3%. In conclusion, inhibition of Fascin-1 expression in Hep-2 cells could break the integrity of cytoskeleton and decrease the ability of cellular immigration.
    Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 10/2010; 27(5):1034-8.
  • Article: Can Epstein-Barr virus infection be the primary etiological factor to nasopharyngeal carcinoma?
    Yan Lin, Jingjing Zhang, Shixi Liu
    Medical Hypotheses 05/2010; 74(5):956-7. · 1.39 Impact Factor
  • Article: Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis.
    [show abstract] [hide abstract]
    ABSTRACT: To date there is no information on the expression of mediators associated with tissue remodeling in Asian patients with chronic rhinitis with (CRSwNP) or without (CRSsNP) nasal polyps. To study the expression of TGF-beta1, matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs), collagen, and regulatory T cells in Chinese patients with CRSwNP and CRSsNP. Thirty-six male and female subjects (12 patients with CRSwNP, 12 patients with CRSsNP, and 12 control subjects), age 17 to 60 years, were recruited into the study. Samples were collected from polyp and sinusoidal mucosal, ethmoidal mucosal, or inferior turbinate in the respective groups and assessed for TGF- beta1, MMP-2, MMP-7, MMP-9, TIMP-1, TIMP-2, TIMP-3, and TIMP-4 by immunoassay; collagen by histochemistry; and forkhead box P3 (FOXP3) mRNA by real-time PCR. Patients with CRSwNP showed significantly lower concentrations of TGF-beta1, TIMP-1, TIMP-4, FOXP3, and collagen compared with patients with CRSsNP. Although there were no significant differences between the concentrations of MMP-7 and MMP-9 in patients with CRSwNP and CRSsNP, these were significantly increased compared with control patients. MMP-2 and TIMP-2 concentrations were not significantly different in any patient group, whereas TIMP-3 was not detectable. Chronic rhinosinusitis with nasal polyps is characterized by a relative lack of TGF-ss expression versus CRSsNP. This finding may be causal for decreased collagen, TIMP-1/4, and FOXP3 expression in CRSwNP versus CRSsNP. TGF-ss serves as a main switch for different remodeling patterns in sinus disease.
    The Journal of allergy and clinical immunology 04/2010; 125(5):1061-8. · 9.17 Impact Factor
  • Article: Endonasal endoscopic repair of cerebrospinal fluid rhinorrhea in a series of 69 patients.
    [show abstract] [hide abstract]
    ABSTRACT: We presented our experiences in treatment of Cerebrospinal Fluid (CSF) rhinorrhea with an endoscopic endonasal surgery approach, and showed the severe postoperative complications and failures we experienced, in order to outline some of the characteristic problems that can occur. We performed a retrospective analysis of all of the patients with CSF rhinorrhea. All of the patients were managed with an endonasal endoscopic procedure. Data collected included the site of leakage, the surgical interventions, and the postoperative complications. Sixty-nine patients (33 females and 36 males) were included in this study. All patients underwent an endoscopic repair approach with a multilayer reconstructive technique. The success rates of the first attempt in our study were 89%. Four patients presented with postoperative meningitis and brain abscess and one of these patients died of the brain abscess. Our results indicate that an endoscopic endonasal surgery approach provides a wide, safe, and direct route for treatment of CSF rhinorrhea. The precise location of leakage prior to surgery and proper patient selection, eliminating those with large leakages, are helpful in ensuring a successful endoscopic CSF repair with minimal mortality.
    British Journal of Neurosurgery 03/2010; 24(3):244-8. · 0.88 Impact Factor
  • Article: Remodeling and inflammation in Chinese versus white patients with chronic rhinosinusitis.
    The Journal of allergy and clinical immunology 02/2010; 125(2):507; author reply 507-8. · 9.17 Impact Factor
  • Article: Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    [show abstract] [hide abstract]
    ABSTRACT: Fascin-1 and E-cadherin, both of which are related to cell motility and cell adhesiveness, are important factors in the progression and metastasis of cancers. The objective of this study was to explore the association between fascin-1 and E-cadherin expression levels with both the clinical characteristics and prognoses of patients with laryngeal squamous cell carcinoma; we did so through statistical analyses. In our study, tumor tissue samples from 150 patients with laryngeal squamous cell carcinoma were examined for fascin-1 and E-cadherin expression by immunohistochemistry. Fascin-1 expression was found to be an independent predictive factor for recurrence in patients with laryngeal squamous cell carcinoma (P = 0.021) and independently related to disease-free survival (P = 0.010). Although E-cadherin expression status was not an independent predictive factor for recurrence (P = 0.055) or disease-free survival (P = 0.063), when using subgroup analysis, the subgroup with high fascin-1 expression/low E-cadherin expression had the poorest prognosis (P = 0.000). Fascin-1 expression could be a potential prognostic predictor for patients with laryngeal squamous cell carcinoma. Simultaneous analyses of fascin-1 and E-cadherin expression could be more effective in evaluating the prognoses of patients with laryngeal squamous cell carcinoma.
    European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) 10/2009; 19(1):11-7. · 2.21 Impact Factor
  • Article: Injection of plasmin in local area: a new treatment option for nasal polypsis.
    Xiaoyuan Li, Shixi Liu
    [show abstract] [hide abstract]
    ABSTRACT: Nasal polypsis(NP), is one of the most difficult challenges in otorhinolaryngology, as the aetiology and pathophysiology are largely unknown unfortunately, medical treatment is unsatisfactory, and, because of frequent recurrences, repeated surgical interventions are often necessary. Now in clinic, the therapy for NP involves a combination of observation, medical, and surgical treatments. But with both treatments of medical and surgical, recurrences are still common. In nasal polypsis, although fibrotic changes do not dominate, myofibroblasts are significantly more abundant in the pedicle where the polyps can be thought to "grow" than in the central or tip areas. But in the "health" nasal mucosa, myofibroblasts can not been observed. Under normal conditions, when the injury is recovery, myofibroblats subsequent disappear from the injured site due to apoptosis. It is very interesting that myofibroblasts can survival in nasal polyps. We hypothesize here that, in nasal polyps, myofibroblasts adopt strategies to avoid apoptosis and consequent clearance by the immune system. In the "grow" area where the conditions are unchecked, deranged or repeated tissue repair, myofibroblasts, as the key factors, push about the formation or growth of the nasal polyps. So we try injecting plasmin in the pedicle of nasal polypsis to promote myofibroblast apoptosis, which may lead to a new treatment option for this incapacitating disease.
    Medical Hypotheses 06/2009; 73(5):807-8. · 1.39 Impact Factor
  • Article: Inhibition of ataxia-telangiectasia mutated by antisense oligonucleotide nanoparticles induces radiosensitization of head and neck squamous-cell carcinoma in mice.
    [show abstract] [hide abstract]
    ABSTRACT: Ataxia-telangiectasia-mutated (ATM) is a radiosensitization gene. In the present study, we investigated the efficacy of poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles containing ATM antisense oligonucleotides (ASOs) for the radiosensitization of head and neck squamous-cell carcinoma in mice, using the SCCVII cell line. Nanoparticles containing ATM ASOs were prepared with PLGA by using a double-emulsion solvent evaporation method. The results showed that the nanoparticles were suitable for intracellular uptake, and ATM ASOs inhibited ATM expression when delivered by using nanoparticles or lipofectin, but not in their free form. Meanwhile, we found that ATM reduction sensitized SCCVII cells in vitro and tumors in vivo to irradiation. In conclusion, biodegradable PLGA nanoparticles, used as a delivery carrier, enhanced intracellular uptake of ATM ASOs into SCCVII cells and the inhibitory effect of ATM ASOs. These results demonstrated that antisense ATM therapy, using PLGA nanoparticles, might provide a therapeutic benefit to patients undergoing radiation therapy for head and neck squamous-cell carcinoma.
    Cancer Biotherapy & Radiopharmaceuticals 06/2009; 24(3):339-46. · 1.44 Impact Factor
  • Article: [Clinical study on submental island flaps in repairing pharyngeal fistula].
    [show abstract] [hide abstract]
    ABSTRACT: To explore the application of submental island flaps in repairing pharyngeal fistula after total laryngectomy. From July 2002 to February 2006, 9 cases of concomitant pharyngeal fistula (including 7 cases of laryngeal carcinoma and 2 cases of hypopharyngeal neoplasms) were repaired with submental island flaps after total laryngectomy. All patients were male and their ages were 52-71 years (mean 61.8 years). Pharyngeal fistula occurred 5-62 days (mean 14.7 days) after total laryngectomy. The diameter of medial pharyngeal fistula ranged from 1.9 cm to 4.1 cm. All patients failed to respond to conservative therapy for 25-46 days. The size of submental island flap was 2.5 cm x 2.4 cm to 4.6 cm x 4.0 cm. After the pharyngeal fistula were repaired with submental flap, the donor site were sutured directly. All of the nine submental flaps were survived and no local necrosis or wound infection occurred. Incision at donor site healed by first intention and no obvious scar formed. Fistula occurred 10 days after operation and was cured after symptomatic treatment in one patient who received radiotherapy before operation; other patients achieved the satisfactory results of one-stage repair. The gastric tube was pulled out 14 to 22 days after operation, all of the patients have no sense of swallow obstruction. Nine patients were followed up for 10-38 months (mean 27 months). The appearance of neck was satisfactory. Because of its short distance, abundant blood supply, convenient operation and minimal donor-site morbidity, the submental island flap is a good alternative method in repairing pharyngeal fistula.
    Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 04/2009; 23(3):322-4.
  • Article: Stomal recurrence after total laryngectomy: a clinicopathological multivariate analysis.
    [show abstract] [hide abstract]
    ABSTRACT: To evaluate the possible risk factors associated with recurrence of stomal recurrence after total laryngectomy that may be used as evidence of the efficacy of select preventive procedures. Various clinicopathologic factors of 548 patients who underwent total laryngectomy for laryngeal cancer at our hospital between January 1995 and December 2004 were reviewed. Univariate and multivariate logistic regression models were constructed to evaluate the risk factors for odds ratio (OR) and statistical significance. Recurrence of stomal recurrence was observed in 48 cases and the median time to recurrence was 9.1 months. Univariate analysis showed that primary location (P = 0.000), T-stage (P = 0.000), preoperative tracheotomy (P = 0.001), and positive surgical margin (P = 0.000) were significant factors associated with stomal recurrence. Preoperative tracheotomy had no effect on the incidence of stomal recurrence in the T3 or T4 subgroups. Multivariate analysis showed that T-stage (OR = 1.687; P = 0.049), primary location (OR = 2.387; P = 0.012), and surgical margin (OR = 2.278; P = 0.020) were independent predictive factors for stomal recurrence. The prognosis of patients with stomal recurrence after laryngectomy is very poor. Identification of patients with high-risk factors is essential for offering more selective treatments to prevent their evolution.
    American journal of clinical oncology 04/2009; 32(2):154-7. · 2.21 Impact Factor
  • Source
    Article: Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice.
    [show abstract] [hide abstract]
    ABSTRACT: Treatment failure after radiotherapy of head and neck squamous cell carcinoma (HNSCC) could be a significant problem. Our objective is to sensitize SCCVII cells to ionizing radiation in vitro and in vivo through inhibiting ATM expression using antisense oligodeoxynucleotides (AS-ODNs), and investigate the potential mechanism of radiosensitization. We designed and synthesized AS-ODNs that target ATM mRNA to reduce the ATM expression. The influence on the expression of ATM mRNA and protein in SCCVII cells were analysed by real-time quantitative PCR and western blotting respectively. Clonogenic survival assay was performed to detect the survival ability of SCCVII cells after irradiation, while flow cytometry used to analyse the cell cycle and apoptosis. The volume of solid tumors generated with SCCVII cells was measured, and cell apoptosis was analysed by TUNEL assay after irradiation. The relative ATM mRNA and protein expression in SCCVII cells treated with ATM AS-ODNs were decreased to 25.7 +/- 3.1% and 24.1 +/- 2.8% of that in untreated cells respectively (P < 0.05). After irradiation, the survival fraction (SF) of cells treated with ATM AS-ODNs was lower than that of other groups at the same dose of radiation (P < 0.05), while the percentage of cells in G2/M phase decreased and apoptotic rate of cells increased (P < 0.05). The inhibition rate in SCCVII cells solid tumor exposed to X-ray alone was 23.2 +/- 2.7%, while it was 56.1 +/- 3.8% in the group which irradiated in combination with the treatment of ATM AS-ODNs (P < 0.05). The apoptotic index for the group irradiated in combination with ATM AS-ODNs injection was 19.6 +/- 3.2, which was significantly higher than that of others (P < 0.05) Inhibition of ATM expression sensitized SCCVII cells to ionizing radiation in vitro and in vivo. The potential mechanism should be the defective G2/M cell cycle checkpoint control and enhanced radiation-induced apoptosis.
    Journal of Experimental & Clinical Cancer Research 10/2008; 27:56. · 2.15 Impact Factor
  • Article: Primary vocal cord aspergillosis caused by Aspergillus fumigatus and molecular identification of the isolate.
    [show abstract] [hide abstract]
    ABSTRACT: This is a case of vocal cord aspergillosis in a 36-year-old woman whose chief complaint was progressive hoarseness and vocal fatigue of one month duration. These symptoms followed the use of systemic administration of penicillin, cefotaxime natrium and dexamethasone to treat her rhinitis and asthma. Fiberoptic laryngoscopy revealed whitish plaques involving both vocal cords. Microscopic examination of KOH preparations and histopathology studies of tissue revealed dichotomously branching, hyaline, septate hyphae. Morphological and molecular biological identification of the fungal growth in cultures inoculated with clinical specimens from the patient indicated that the etiologic agent was Aspergillus fumigatus. The patient was cured with oral itraconazole without any side effects.
    Medical Mycology 08/2008; 46(5):475-9. · 2.46 Impact Factor

Institutions

  • 2006–2011
    • West China University of Medical Sciences
      • Department of Otolaryngology Head-Neck Surgery
      Chengdu, Sichuan Sheng, China
    • West China Hospital of Stomatology
      Chengdu, Sichuan Sheng, China
  • 2002–2010
    • Sichuan University
      • Medical School
      Chengdu, Sichuan Sheng, China
  • 2008
    • Luzhou Medical College
      Luzhou, Sichuan Sheng, China